Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Obesity is a chronic condition and a key risk factor for a range of other health issues, including type 2 diabetes. In a ...

Gaffigan admitted to having trepidation to use the medication, a brand name for tirzepatide, after tipping the scales at 270 ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

Artemis Bayandor from Illinois in the US lost over a stone after starting to take game-changing weight-loss jabs, but like ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

Eli Lilly proposed a plan to ensure 340B entities pay no more than the ceiling price by providing them with cash directly on ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...